---
title: "石四藥集團：苯磺酸左氨氯地平片獲藥品生產註冊批件"
description: "智通財經 APP 訊，石四藥集團發佈公告，本集團已取得中國國家藥品監督管理局有關苯磺酸左氨氯地平片 (5mg 及 2.5mg) 的藥品生產註冊批件，均屬於化學藥品第 4 類，視同通過一致性評價。苯磺酸左氨氯地平片主要用於高血壓、慢性穩定性心絞痛及血管痙攣性心絞痛的治療，可單獨應用或與其他藥物聯合應用。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/261547438.md"
published_at: "2025-10-17T04:10:05.000Z"
---

# 石四藥集團：苯磺酸左氨氯地平片獲藥品生產註冊批件

> 智通財經 APP 訊，石四藥集團發佈公告，本集團已取得中國國家藥品監督管理局有關苯磺酸左氨氯地平片 (5mg 及 2.5mg) 的藥品生產註冊批件，均屬於化學藥品第 4 類，視同通過一致性評價。苯磺酸左氨氯地平片主要用於高血壓、慢性穩定性心絞痛及血管痙攣性心絞痛的治療，可單獨應用或與其他藥物聯合應用。

智通財經 APP 訊，石四藥集團 (02005) 發佈公告，本集團已取得中國國家藥品監督管理局有關苯磺酸左氨氯地平片 (5mg 及 2.5mg) 的藥品生產註冊批件，均屬於化學藥品第 4 類，視同通過一致性評價。

苯磺酸左氨氯地平片主要用於高血壓、慢性穩定性心絞痛及血管痙攣性心絞痛的治療，可單獨應用或與其他藥物聯合應用。

### Related Stocks

- [02005.HK - 石四藥集團](https://longbridge.com/zh-HK/quote/02005.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| SSY Group Ltd. Secures Chinese Regulatory Approval for Levamlodipine Besilate Tablets | SSY Group Ltd. has received approval from China's National Medical Products Administration for Levamlodipine Besilate Ta | [Link](https://longbridge.com/zh-HK/news/261547083.md) |
| SSY Group Wins China Approval for New Hypertension Combination Drug | SSY Group Limited has received approval from China's National Medical Products Administration for its Perindopril Argini | [Link](https://longbridge.com/zh-HK/news/271492775.md) |
| 08:01 ETNew "Hypertension Bites" Campaign Urges Adults to Prioritize Blood Pressure Control | The Hypertension Control Alliance has launched the "Hypertension Bites" campaign to raise awareness about the importance | [Link](https://longbridge.com/zh-HK/news/275760090.md) |
| Towa Pharmaceutical (TSE:4553) Margin Firmness Reinforces Defensive Earnings Narrative In Q3 2026 | Towa Pharmaceutical (TSE:4553) reported solid Q3 2026 results with revenue of ¥73.6b and net income of ¥8.9b, reflecting | [Link](https://longbridge.com/zh-HK/news/275991027.md) |
| SSY Group Wins Chinese Government Bid to Supply Medicines to Healthcare Facilities | SSY Group Wins Chinese Government Bid to Supply Medicines to Healthcare Facilities | [Link](https://longbridge.com/zh-HK/news/263006264.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。